Stocks To Buy Today: Laurus Labs, Aurobindo Pharma, JK Cement, Astral And Delhivery

Analysts have advised investors to buy Laurus Labs Ltd., Aurobindo Pharma Ltd., JK Cement Ltd., Astral Ltd. and Delhivery Ltd. among other stocks.

Vikas Jain, head of research at Reliance Securities, Dr. Ravi Singh, SVP retail research, Religare Broking and Aditya Arora, founder and multi asset research analyst, at Adlytick.in shared their insights with NDTV Profit.

These stocks could see potential upsides of up to 12%.

Jain recommends purchasing the stock at Rs 328.8, with a target of Rs 369 and a stop loss of Rs 303. Over the past year, the stock has fallen 27.89%. Its relative strength index was at 54.98.

As per Bloomberg data, 24 analysts cover the stock, with 19 assigning a 'buy' rating and five a 'hold'. The 12-month analysts' consensus target is Rs 449.6, offering an expected upside of 36.7%.

Arora also recommends buying Laurus Labs stock at Rs 612, with a target of Rs 655 and a stop loss at Rs 570. Over the past year, the stock has moved 58.21%. Its relative strength index was at 52.

Of the 16 analysts covering the stock, six have a 'buy' rating, four a 'hold' and six a 'sell', as per Bloomberg data. The 12-month analysts' consensus target is Rs 584.2, offering an expected downside of 4.5%.

According to Arora, the stock is a 'buy' at the current level, with a target price of Rs 1,215 and a stop loss at Rs 1,131. It has gained 15.03% in the last 12 months. The stock’s relative strength index stands was 52.04.

Bloomberg data indicates 29 analysts cover the stock, with 21 giving it a 'buy', four a 'hold' and four suggesting a 'sell'. Analysts' consensus for the next 12 months sets the target at Rs 1,517, suggesting an upside of 30%.

Singh advises buying the stock at Rs 4,885, targeting Rs 5,050 with a stop loss at Rs 4,790. The stock has risen 13.01% in the past 12 months. The relative strength index was recorded at 55.

Bloomberg data indicates 27 analysts cover the stock, with 20 giving it a 'buy', four a 'hold' and three suggesting a 'sell'. Analysts' consensus for the next 12 months sets the target at Rs 5,078, suggesting an upside of 4.5%.

Singh recommends purchasing the stock with target of Rs 1,545 per share and a stop loss at Rs 1,478. Over the past year, the stock has fallen 19.74%. Its relative strength index is currently at 57.

Of the 27 analysts covering the stock, 19 have a 'buy' rating, four a 'hold' and four a 'sell', according to Bloomberg data. The 12-month analysts' consensus target is Rs 1,756, offering an expected upside of 16.7%.

Disclaimer: The views and opinions expressed by the investment advisers on NDTV Profit are of their own and not of NDTV Profit. NDTV Profit advises users to consult with their own financial or investment adviser before taking any investment decision.